Ruzica Ranevski

Title: Ruzica Ranevski: Innovator in Pharmaceutical and Cosmetic Compositions

Introduction

Ruzica Ranevski is a notable inventor based in Basel, Switzerland. She has made significant contributions to the field of pharmaceutical and cosmetic compositions, particularly through her innovative work with Enamel Matrix Derivative (EMD) proteins. Her research focuses on the regeneration of hard tissues and the promotion of bone growth.

Latest Patents

Ranevski holds a patent for a purified EMD protein composition. This pharmaceutical, dental, and cosmetic composition consists of purified EMD proteins with a molecular weight between 1 and 55 kDa. The formulation is designed to be effective in promoting and inducing regeneration of hard tissue, tissue mineralization, and bone regrowth. The composition is specifically depleted of proteins with a molecular weight between 56 and 160 kDa and proteinase inhibitors, ensuring its efficacy in various medical applications.

Career Highlights

Ruzica Ranevski is currently associated with Straumann Holding AG, a leading company in the dental and orthopedic sectors. Her work has been instrumental in advancing the understanding and application of EMD proteins in regenerative medicine. With her innovative approach, she has contributed to the development of solutions that enhance tissue healing and regeneration.

Collaborations

Ranevski has collaborated with esteemed colleagues such as Peter S. Zilm and P. Mark Bartold. These partnerships have further enriched her research and have led to advancements in the field of dental and pharmaceutical sciences.

Conclusion

Ruzica Ranevski is a pioneering inventor whose work in purified EMD protein compositions has the potential to revolutionize regenerative medicine. Her contributions continue to impact the fields of dentistry and pharmaceuticals positively.